Le Lézard
Classified in: Health, Business
Subjects: SVY, ECO, TRD

Dialogues économiques: Study of The Increased Obesity Rate to Mexico


MARSEILLE, France , June 8, 2022 /CNW/ -- Over just a few decades, obesity has become the public enemy for wealthy and developing countries alike. Third-world nations saw their overweight rate triple since the late 1980s, which happened to coincide with their growing place within global trade.

Between 1988 and 2012, the rate of obesity among Mexican women increased from 10% to 30%. At the same time, Mexico entered a period of greater economic liberalization by signing the NAFTA trade pact with the United States and Canada. This led many experts to examine the link between globalization and health issues related to food.

According to the economists Osea Giuntella, Matthias Rieger, and Lorenzo Rotunno, the arrival of American products onto the Mexican market accounts for up to 20% of the increase in obesity among Mexican women.

The American Weight of Life 

Since the NAFTA trade pact was signed in 1994, American exports (particularly in food products) to Mexico has soared. In 2012, American food products (of both food and beverage) represented 75% of all Mexican imports. This equaled to 8% of all Mexican household spending?compared to 2% in 1989! These numbers make the United States the number one provider of food products to Mexico and a heavy hitter in the dietary habits of the country's population.

Their analysis goes beyond the situation with Mexico. Their results demonstrate a causal link between trade and obesity, and they lead us to reflect on how globalization could negatively affect health. In this context, trade policies can influence a population's food quality, transform its habits, and finally impact its health. So, the question arises: can we continue to allow players to enter the global trade market while protecting people's health as well as the environment?

Discover more about this topic and how economy impacts all aspects of our life with Dialogues Economiques and its newsletter

About Dialogues Economiques

Dialogues Economiques is an online outreach journal, edited by Aix-Marseille School of Economics.. Its originality stems from its approach: Our articles are based on papers published in peer-reviewed journals and co-written by journalists and researchers. 

About us | Dialogues Économiques (dialogueseconomiques.fr)

CONTACT

[email protected]
Dialogues Économiques | Tune in to research (dialogueseconomiques.fr)
https://twitter.com/amseaixmars
https://www.facebook.com/dialogueseconomiques/
https://www.youtube.com/channel/UCDZyLoQ72eG8QyXk7tt7VLA

Photo - https://mma.prnewswire.com/media/1834582/Dialogues_economiques.jpg
Logo - https://mma.prnewswire.com/media/1834581/Dialogues_Economiques_Logo.jpg

 

SOURCE Dialogues économiques , edited by Aix-Marseille School of Economics


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: